Global Nuclear Medicine Market 2020 by Company, Type and Application, Forecast to 2025

  • receipt Report ID : 94770
  • calendar_today Published On: Aug, 2020
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

Market Overview

The Nuclear Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Nuclear Medicine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.1%% in the forecast period of 2020 to 2025 and will expected to reach USD 7219.3 million by 2025, from USD 5490.7 million in 2019.

Market segmentation

Nuclear Medicine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.

Breakdown by Type, Nuclear Medicine market has been segmented into Tc-99, I-123/131, In-111, Xe-133, Th-201, Ga-67, Other, etc.

Breakdown by Application, Nuclear Medicine has been segmented into Diagnostic, Therapeutic, etc.

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Nuclear Medicine market presented in the report. This section sheds light on the sales growth of different regional and country-level Nuclear Medicine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nuclear Medicine market.

For Japan, this report analyses the Japan market by players, Type and Application, for the period 2015-2025.

Competitive Landscape and Nuclear Medicine Market Share Analysis

Nuclear Medicine competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Nuclear Medicine revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nuclear Medicine revenue and market share for each player covered in this report.

The major players covered in Nuclear Medicine are: GE Healthcare, Jubilant Pharma, Lantheus Medical Imaging, Bracco Imaging, Nordion, Mallinckrodt, SIEMENS, Triad Isotopes, Bayer, Eli Lilly, China Isotope & Radiation, Dongcheng, etc. Among other players domestic and global, Nuclear Medicine market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Market segment by players, this report covers

GE Healthcare

Jubilant Pharma

Lantheus Medical Imaging

Bracco Imaging

Nordion

Mallinckrodt

SIEMENS

Triad Isotopes

Bayer

Eli Lilly

China Isotope & Radiation

Dongcheng

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina)

MENA (Saudi Arabia, UAE, Turkey and South Africa)

Market segment by Type, covers:

Tc-99

I-123/131

In-111

Xe-133

Th-201

Ga-67

Other

Market segment by Application, can be divided into

Diagnostic

Therapeutic

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Nuclear Medicine

1.2 Classification of Nuclear Medicine by Type

1.2.1 Overview: Global Nuclear Medicine Revenue by Type: 2015 Versus 2019 Versus 2025

1.2.2 Global Nuclear Medicine Revenue Market Share by Type in 2019

1.2.3 Tc-99

1.2.4 I-123/131

1.2.5 In-111

1.2.6 Xe-133

1.2.7 Th-201

1.2.8 Ga-67

1.2.9 Other

1.3 Global Nuclear Medicine Market by Application

1.3.1 Overview: Global Nuclear Medicine Revenue by Application: 2015 Versus 2019 Versus 2025

1.3.2 Diagnostic

1.3.3 Therapeutic

1.4 Global Nuclear Medicine Market Size and Forecast (2015-2025)

1.5 Global Nuclear Medicine Market Size by Regions: 2015 VS 2019 VS 2025

1.6 Global Nuclear Medicine Market Size by Regions (2015-2020)

1.7 Global Nuclear Medicine Market Size and Forecast by Regions (2020-2025)

1.7.1 North America Nuclear Medicine Status and Prospect (2015-2025)

1.7.2 Europe Nuclear Medicine Status and Prospect (2015-2025)

1.7.3 Asia Nuclear Medicine Status and Prospect (2015-2025)

1.7.4 South America Nuclear Medicine Status and Prospect (2015-2025)

1.7.5 Middle East & Africa Nuclear Medicine Status and Prospect (2015-2025)

2 Company Profiles

2.1 GE Healthcare

2.1.1 GE Healthcare Details

2.1.2 GE Healthcare Major Business

2.1.3 GE Healthcare SWOT Analysis

2.1.4 GE Healthcare Product and Services

2.1.5 GE Healthcare Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2019)

2.2 Jubilant Pharma

2.2.1 Jubilant Pharma Details

2.2.2 Jubilant Pharma Major Business

2.2.3 Jubilant Pharma SWOT Analysis

2.2.4 Jubilant Pharma Product and Services

2.2.5 Jubilant Pharma Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2019)

2.3 Lantheus Medical Imaging

2.3.1 Lantheus Medical Imaging Details

2.3.2 Lantheus Medical Imaging Major Business

2.3.3 Lantheus Medical Imaging SWOT Analysis

2.3.4 Lantheus Medical Imaging Product and Services

2.3.5 Lantheus Medical Imaging Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2019)

2.4 Bracco Imaging

2.4.1 Bracco Imaging Details

2.4.2 Bracco Imaging Major Business

2.4.3 Bracco Imaging SWOT Analysis

2.4.4 Bracco Imaging Product and Services

2.4.5 Bracco Imaging Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2019)

2.5 Nordion

2.5.1 Nordion Details

2.5.2 Nordion Major Business

2.5.3 Nordion SWOT Analysis

2.5.4 Nordion Product and Services

2.5.5 Nordion Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2019)

2.6 Mallinckrodt

2.6.1 Mallinckrodt Details

2.6.2 Mallinckrodt Major Business

2.6.3 Mallinckrodt Product and Services

2.6.4 Mallinckrodt Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2019)

2.7 SIEMENS

2.7.1 SIEMENS Details

2.7.2 SIEMENS Major Business

2.7.3 SIEMENS Product and Services

2.7.4 SIEMENS Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2019)

2.8 Triad Isotopes

2.8.1 Triad Isotopes Details

2.8.2 Triad Isotopes Major Business

2.8.3 Triad Isotopes Product and Services

2.8.4 Triad Isotopes Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2019)

2.9 Bayer

2.9.1 Bayer Details

2.9.2 Bayer Major Business

2.9.3 Bayer Product and Services

2.9.4 Bayer Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2019)

2.10 Eli Lilly

2.10.1 Eli Lilly Details

2.10.2 Eli Lilly Major Business

2.10.3 Eli Lilly Product and Services

2.10.4 Eli Lilly Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2019)

2.11 China Isotope & Radiation

2.11.1 China Isotope & Radiation Details

2.11.2 China Isotope & Radiation Major Business

2.11.3 China Isotope & Radiation Product and Services

2.11.4 China Isotope & Radiation Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2019)

2.12 Dongcheng

2.12.1 Dongcheng Details

2.12.2 Dongcheng Major Business

2.12.3 Dongcheng Product and Services

2.12.4 Dongcheng Nuclear Medicine Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

3.1 Global Nuclear Medicine Market Size by Players (2015-2020)

3.2 Japan Nuclear Medicine Market Size by Players (2015-2020)

3.3 Market Concentration Rate

3.3.1 Top 5 Nuclear Medicine Players Market Share

3.3.2 Top 10 Nuclear Medicine Players Market Share

4 North America Market Size and Forecast by Countries

4.1 North America Nuclear Medicine Market Size by Countries (2015-2020)

4.2 North America Nuclear Medicine Market Size and Forecast by Countries (2015-2026)

4.3 United States Nuclear Medicine Market Size and Forecast (2015-2025)

4.4 Canada Nuclear Medicine Market Size and Forecast (2015-2025)

4.5 Mexico Nuclear Medicine Market Size and Forecast (2015-2025)

5 Europe Market Size and Forecast by Countries

5.1 Europe Nuclear Medicine Market Size by Countries (2015-2020)

5.2 Europe Nuclear Medicine Market Size and Forecast by Countries (2015-2026)

5.3 Germany Nuclear Medicine Market Size and Forecast (2015-2025)

5.4 France Nuclear Medicine Market Size and Forecast (2015-2025)

5.5 UK Nuclear Medicine Market Size and Forecast (2015-2025)

5.6 Russia Nuclear Medicine Market Size and Forecast (2015-2025)

5.7 Italy Nuclear Medicine Market Size and Forecast (2015-2025)

6 Asia-Pacific Market Size and Forecast by Countries

6.1 Asia-Pacific Nuclear Medicine Market Size by Regions (2015-2020)

6.2 Asia-Pacific Nuclear Medicine Market Size and Forecast by Regions (2015-2026)

6.3 China Nuclear Medicine Market Size and Forecast (2015-2025)

6.4 Japan Nuclear Medicine Market Size and Forecast (2015-2025)

6.5 Korea Nuclear Medicine Market Size and Forecast (2015-2025)

6.6 India Nuclear Medicine Market Size and Forecast (2015-2025)

6.7 Southeast Asia Nuclear Medicine Market Size and Forecast (2015-2025)

7 South America Market Size and Forecast by Countries

7.1 South America Nuclear Medicine Market Size by Countries (2015-2020)

7.2 South America Nuclear Medicine Market Size and Forecast by Countries (2015-2026)

7.3 Brazil Nuclear Medicine Market Size and Forecast (2015-2025)

7.4 Argentina Nuclear Medicine Market Size and Forecast (2015-2025)

8 Middle East & Africa Market Size and Forecast by Countries

8.1 Middle East & Africa Nuclear Medicine Revenue by Regions (2015-2020)

8.2 Middle East & Africa Nuclear Medicine Market Size and Forecast by Countries (2015-2026)

8.3 Saudi Arabia Nuclear Medicine Market Size and Forecast (2015-2025)

8.4 UAE Nuclear Medicine Market Size and Forecast (2015-2025)

8.5 Egypt Nuclear Medicine Market Size and Forecast (2015-2025)

8.6 South Africa Nuclear Medicine Market Size and Forecast (2015-2025)

9 Market Size Segment by Type

9.1 Global Nuclear Medicine Market Size and Forecast by Type (2015-2025)

9.1.1 Global Nuclear Medicine Market Size by Type (2015-2020)

9.1.2 Global Nuclear Medicine Market Size Forecast by Type (2020-2025)

9.2 Japan Nuclear Medicine Market Size and Forecast by Type (2015-2025)

9.2.1 Japan Nuclear Medicine Market Size by Type (2015-2020)

9.2.2 Japan Nuclear Medicine Market Size Forecast by Type (2020-2025)

10 Market Size Segment by Application

10.1 Global Nuclear Medicine Market Size and Forecast by Application (2015-2025)

10.1.1 Global Nuclear Medicine Market Size by Application (2015-2020)

10.1.2 Global Nuclear Medicine Market Size Forecast by Application (2020-2025)

10.2 Japan Nuclear Medicine Market Size and Forecast by Application (2015-2025)

10.2.1 Japan Nuclear Medicine Market Size by Application (2015-2020)

10.2.2 Japan Nuclear Medicine Market Size Forecast by Application (2020-2025)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Data Source

12.3 Disclaimer

12.4 About US

List of Tables

Table 1. Global Nuclear Medicine Revenue (USD Million) by Type: 2015 Versus 2019 Versus 2025

Table 2. Breakdown of Nuclear Medicine by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Nuclear Medicine Revenue (USD Million) by Application: 2015 Versus 2019 Versus 2025

Table 4. Global Market Nuclear Medicine Market Size (USD Million) Comparison by Regions (2020-2025)

Table 5. Global Nuclear Medicine Revenue (USD Million) by Regions (2015-2020)

Table 6. Global Nuclear Medicine Revenue Share by Regions (2015-2020)

Table 7. Global Nuclear Medicine Revenue (USD Million) by Regions (2020-2025)

Table 8. Global Nuclear Medicine Revenue Market Share by Regions (2020-2025)

Table 9. Global Nuclear Medicine Market Size and Growth Estimation in Various Scenarios in 2020

Table 10. GE Healthcare Corporate Information, Location and Competitors

Table 11. GE Healthcare Major Business

Table 12. GE Healthcare Nuclear Medicine Total Revenue (USD Million) (2017-2018)

Table 13. GE Healthcare SWOT Analysis

Table 14. GE Healthcare Nuclear Medicine Product and Solutions

Table 15. GE Healthcare Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 16. Jubilant Pharma Corporate Information, Location and Competitors

Table 17. Jubilant Pharma Major Business

Table 18. Jubilant Pharma Nuclear Medicine Total Revenue (USD Million) (2018-2019)

Table 19. Jubilant Pharma SWOT Analysis

Table 20. Jubilant Pharma Nuclear Medicine Product and Solutions

Table 21. Jubilant Pharma Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 22. Lantheus Medical Imaging Corporate Information, Location and Competitors

Table 23. Lantheus Medical Imaging Major Business

Table 24. Lantheus Medical Imaging Nuclear Medicine Total Revenue (USD Million) (2017-2018)

Table 25. Lantheus Medical Imaging SWOT Analysis

Table 26. Lantheus Medical Imaging Nuclear Medicine Product and Solutions

Table 27. Lantheus Medical Imaging Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 28. Bracco Imaging Corporate Information, Location and Competitors

Table 29. Bracco Imaging Major Business

Table 30. Bracco Imaging Nuclear Medicine Total Revenue (USD Million) (2017-2018)

Table 31. Bracco Imaging SWOT Analysis

Table 32. Bracco Imaging Nuclear Medicine Product and Solutions

Table 33. Bracco Imaging Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 34. Nordion Corporate Information, Location and Competitors

Table 35. Nordion Major Business

Table 36. Nordion Nuclear Medicine Total Revenue (USD Million) (2017-2018)

Table 37. Nordion SWOT Analysis

Table 38. Nordion Nuclear Medicine Product and Solutions

Table 39. Nordion Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 40. Mallinckrodt Corporate Information, Location and Competitors

Table 41. Mallinckrodt Major Business

Table 42. Mallinckrodt Nuclear Medicine Total Revenue (USD Million) (2017-2018)

Table 43. Mallinckrodt SWOT Analysis

Table 44. Mallinckrodt Nuclear Medicine Product and Solutions

Table 45. Mallinckrodt Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 46. SIEMENS Corporate Information, Location and Competitors

Table 47. SIEMENS Major Business

Table 48. SIEMENS Nuclear Medicine Total Revenue (USD Million) (2017-2018)

Table 49. SIEMENS SWOT Analysis

Table 50. SIEMENS Nuclear Medicine Product and Solutions

Table 51. SIEMENS Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 52. Triad Isotopes Corporate Information, Location and Competitors

Table 53. Triad Isotopes Major Business

Table 54. Triad Isotopes Nuclear Medicine Total Revenue (USD Million) (2017-2018)

Table 55. Triad Isotopes SWOT Analysis

Table 56. Triad Isotopes Nuclear Medicine Product and Solutions

Table 57. Triad Isotopes Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 58. Bayer Corporate Information, Location and Competitors

Table 59. Bayer Major Business

Table 60. Bayer Nuclear Medicine Total Revenue (USD Million) (2017-2018)

Table 61. Bayer SWOT Analysis

Table 62. Bayer Nuclear Medicine Product and Solutions

Table 63. Bayer Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 64. Eli Lilly Corporate Information, Location and Competitors

Table 65. Eli Lilly Major Business

Table 66. Eli Lilly Nuclear Medicine Total Revenue (USD Million) (2017-2018)

Table 67. Eli Lilly SWOT Analysis

Table 68. Eli Lilly Nuclear Medicine Product and Solutions

Table 69. Eli Lilly Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 70. China Isotope & Radiation Corporate Information, Location and Competitors

Table 71. China Isotope & Radiation Major Business

Table 72. China Isotope & Radiation Nuclear Medicine Total Revenue (USD Million) (2017-2018)

Table 73. China Isotope & Radiation SWOT Analysis

Table 74. China Isotope & Radiation Nuclear Medicine Product and Solutions

Table 75. China Isotope & Radiation Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 76. Dongcheng Corporate Information, Location and Competitors

Table 77. Dongcheng Major Business

Table 78. Dongcheng Nuclear Medicine Total Revenue (USD Million) (2017-2018)

Table 79. Dongcheng SWOT Analysis

Table 80. Dongcheng Nuclear Medicine Product and Solutions

Table 81. Dongcheng Nuclear Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 82. Global Nuclear Medicine Revenue (USD Million) by Players (2015-2020)

Table 83. Global Nuclear Medicine Revenue Share by Players (2015-2020)

Table 84. Key Players Nuclear Medicine Revenue (USD Million) in Japan (2015-2020)

Table 85. Key Players Nuclear Medicine Revenue Share in Japan (2015-2020)

Table 86. North America Nuclear Medicine Revenue (USD Million) by Countries (2015-2020)

Table 87. North America Nuclear Medicine Revenue Market Share by Countries (2015-2020)

Table 88. North America Nuclear Medicine Revenue (USD Million) by Countries (2020-2026)

Table 89. North America Nuclear Medicine Revenue Market Share by Countries (2020-2026)

Table 90. Europe Nuclear Medicine Revenue (USD Million) by Countries (2015-2020)

Table 91. Europe Nuclear Medicine Revenue Market Share by Countries (2015-2020)

Table 92. Europe Nuclear Medicine Revenue (USD Million) by Countries (2020-2026)

Table 93. Europe Nuclear Medicine Revenue Market Share by Countries (2020-2026)

Table 94. Asia-Pacific Nuclear Medicine Revenue (USD Million) by Countries (2015-2020)

Table 95. Asia-Pacific Nuclear Medicine Revenue Market Share by Countries (2015-2020)

Table 96. Asia-Pacific Nuclear Medicine Revenue (USD Million) by Countries (2020-2026)

Table 97. Asia-Pacific Nuclear Medicine Revenue Market Share by Countries (2020-2026)

Table 98. South America Nuclear Medicine Revenue (USD Million) by Countries (2015-2020)

Table 99. South America Nuclear Medicine Revenue Market Share by Countries (2015-2020)

Table 100. South America Nuclear Medicine Revenue (USD Million) by Countries (2020-2026)

Table 101. South America Nuclear Medicine Revenue Market Share by Countries (2020-2026)

Table 102. Middle East & Africa Nuclear Medicine Revenue (USD Million) by Countries (2015-2020)

Table 103. Middle East & Africa Nuclear Medicine Revenue Market Share by Countries (2015-2020)

Table 104. Middle East & Africa Nuclear Medicine Revenue (USD Million) by Countries (2020-2026)

Table 105. Middle East & Africa Nuclear Medicine Revenue Market Share by Countries (2020-2026)

Table 106. Global Nuclear Medicine Revenue (USD Million) by Type (2015-2020)

Table 107. Global Nuclear Medicine Revenue Share by Type (2015-2020)

Table 108. Global Nuclear Medicine Revenue Forecast by Type (2020-2025)

Table 109. Global Nuclear Medicine Market Share Forecast by Type (2020-2025)

Table 110. Japan Nuclear Medicine Revenue (USD Million) by Type (2015-2020)

Table 111. Japan Nuclear Medicine Revenue Share by Type (2015-2020)

Table 112. Japan Nuclear Medicine Revenue Forecast by Type (2020-2025)

Table 113. Japan Nuclear Medicine Market Share Forecast by Type (2020-2025)

Table 114. Global Nuclear Medicine Revenue (USD Million) by Application (2015-2020)

Table 115. Global Nuclear Medicine Revenue Share by Application (2015-2020)

Table 116. Global Nuclear Medicine Revenue Forecast by Application (2020-2025)

Table 117. Global Nuclear Medicine Market Share Forecast by Application (2020-2025)

Table 118. Japan Nuclear Medicine Revenue (USD Million) by Application (2015-2020)

Table 119. Japan Nuclear Medicine Revenue Share by Application (2015-2020)

Table 120. Japan Nuclear Medicine Revenue Forecast by Application (2020-2025)

Table 121. Japan Nuclear Medicine Market Share Forecast by Application (2020-2025)

Table 122.List of Figures

Table 123. Nuclear Medicine Picture

Table 124. Global Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Table 125. Global Nuclear Medicine Revenue Market Share by Type in 2019

Table 126. Tc-99 Picture

Table 127. I-123/131 Picture

Table 128. In-111 Picture

Table 129. Xe-133 Picture

Table 130. Th-201 Picture

Table 131. Ga-67 Picture

Table 132. Other Picture

Table 133. Nuclear Medicine Revenue Market Share by Application in 2019

Table 134. Diagnostic Picture

Table 135. Therapeutic Picture

Table 136. Global Nuclear Medicine Revenue and Growth Rate (2015-2025) (USD Million)

Table 137. Global Nuclear Medicine Market Size Share by Regions (2015-2025)

Table 138. Global Nuclear Medicine Market Size Share by Regions in 2019

Table 139. Global Nuclear Medicine Revenue Market Share by Regions (2020-2025)

Table 140. North America Nuclear Medicine Revenue (USD Million) and Growth Rate (2015-2025)

Table 141. Europe Nuclear Medicine Revenue (USD Million) and Growth Rate (2015-2025)

Table 142. Asia-Pacific Nuclear Medicine Revenue (USD Million) and Growth Rate (2015-2025)

Table 143. South America Nuclear Medicine Revenue (USD Million) and Growth Rate (2015-2025)

Table 144. Middle East & Africa Nuclear Medicine Revenue (USD Million) and Growth Rate (2015-2025)

Table 145. Global Nuclear Medicine Revenue Share by Players in 2019

Table 146. Global Top 5 Players Nuclear Medicine Revenue Market Share in 2019

Table 147. Top 10 Players Nuclear Medicine Revenue Market Share in Global Market in 2019

Table 148. Global Nuclear Medicine Market Size (USD Million) by Type (2015-2025)

Table 149. Global Nuclear Medicine Market Size Share by Application (2015-2025)

Table 150. North America Nuclear Medicine Market Size Share by Countries (2015-2025)

Table 151. North America Nuclear Medicine Market Size Share by Countries in 2019

Table 152. United States Nuclear Medicine Market Size (USD Million) and Forecast (2015-2025)

Table 153. Canada Nuclear Medicine Market Size (USD Million) and Forecast (2015-2025)

Table 154. Mexico Nuclear Medicine Market Size (USD Million) and Forecast (2015-2025)

Table 155. Europe Nuclear Medicine Market Size Share by Countries (2015-2025)

Table 156. Europe Nuclear Medicine Market Size Share by Countries in 2019

Table 157. Germany Nuclear Medicine Market Size (USD Million) and Forecast (2015-2025)

Table 158. France Nuclear Medicine Market Size (USD Million) and Forecast (2015-2025)

Table 159. Russia Nuclear Medicine Market Size (USD Million) and Forecast (2015-2025)

Table 160. Italy Nuclear Medicine Market Size (USD Million) and Forecast (2015-2025)

Table 161. Spain Nuclear Medicine Market Size (USD Million) and Forecast (2015-2025)

Table 162. UK Nuclear Medicine Market Size (USD Million) and Forecast (2015-2025)

Table 163. Asia Nuclear Medicine Market Size Share by Countries (2015-2025)

Table 164. Asia Nuclear Medicine Market Size Share by Countries in 2019

Table 165. China Nuclear Medicine Market Size (USD Million) and Forecast (2015-2025)

Table 166. Japan Nuclear Medicine Market Size (USD Million) and Forecast (2015-2025)

Table 167. Korea Nuclear Medicine Market Size (USD Million) and Forecast (2015-2025)

Table 168. India Nuclear Medicine Market Size (USD Million) and Forecast (2015-2025)

Table 169. Southeast Asia Nuclear Medicine Market Size (USD Million) and Forecast (2015-2025)

Table 170. South America Nuclear Medicine Market Size Share by Countries (2015-2025)

Table 171. South America Nuclear Medicine Market Size Share by Countries in 2019

Table 172. Brazil Nuclear Medicine Market Size (USD Million) and Forecast (2015-2025)

Table 173. Argentina Nuclear Medicine Market Size (USD Million) and Forecast (2015-2025)

Table 174. Middle East & Africa Nuclear Medicine Market Size Share by Countries (2015-2025)

Table 175. Middle East & Africa Nuclear Medicine Market Size Share by Countries in 2019

Table 176. Saudi Arabia Nuclear Medicine Market Size (USD Million) and Forecast (2015-2025)

Table 177. UAE Nuclear Medicine Market Size (USD Million) and Forecast (2015-2025)

Table 178. Egypt Nuclear Medicine Market Size (USD Million) and Forecast (2015-2025)

Table 179. South Africa Nuclear Medicine Market Size (USD Million) and Forecast (2015-2025)

Table 180. Global Nuclear Medicine Revenue Share by Type (2015-2020)

Table 181. Japan Nuclear Medicine Revenue Share by Type (2015-2020)

Table 182. Global Nuclear Medicine Revenue Share by Application (2015-2020)

Table 183. Japan Nuclear Medicine Revenue Share by Application (2015-2020)